I agree that this site is using cookies. You can find further informations here.
X
Luangdilok, Sutima
20  results:
Search for persons X
?
1

Tissue and Plasma-Based Highly Sensitive Blocker Displaceme..:

Akkhasutthikun, Patinya ; Kaewsapsak, Pornchai ; Nimsamer, Pattaraporn...
Cancer Research and Treatment.  56 (2024)  2 - p. 455-463 , 2024
Link: https://doi.org/10.4143/..
 
?
2

Safety Following COVID-19 Booster Vaccine with BNT162b2 Com..:

Wanchaijiraboon, Passakorn ; Sainamthip, Panot ; Teeyapun, Nattaya...
Vaccines.  11 (2023)  2 - p. 356 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Vaccine-Related adverse events following AZD1222 (ChAdOx1-n..:

Pakvisal, Nussara ; Sainamthip, Panot ; Teeyapun, Nattaya...
Human Vaccines & Immunotherapeutics.  18 (2022)  6 - p. , 2022
Link: https://doi.org/10.1080/..
 
?
4

Immunogenicity after a Third COVID-19 mRNA Booster in Solid..:

Luangdilok, Sutima ; Wanchaijiraboon, Passakorn ; Pakvisal, Nussara...
Vaccines.  10 (2022)  10 - p. 1613 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignan..:

Teeyapun, Nattaya ; Luangdilok, Sutima ; Pakvisal, Nussara...
eClinicalMedicine.  52 (2022)  - p. 101608 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in..:

Wanchaijiraboon, Passakorn ; Teeyapun, Nattaya ; Pakvisal, Nussara...
Vaccines.  10 (2022)  10 - p. 1662 , 2022
Link: https://doi.org/10.3390/..
 
?
7

Association between Pathological Complete Response and Outc..:

Luangdilok, Sutima ; Samarnthai, Norasate ; Korphaisarn, Krittiya
Journal of Breast Cancer.  17 (2014)  4 - p. 376 , 2014
Link: https://doi.org/10.4048/..
 
?
8

MAPK and PI3K signalling differentially regulate angiogenic..:

Luangdilok, Sutima ; Box, Carol ; Harrington, Kevin..
European Journal of Cancer.  47 (2011)  4 - p. 520-529 , 2011
Link: https://doi.org/10.1016/..
 
?
9

Safety Following COVID-19 Booster Vaccine with BNT162b2 Com..:

Wanchaijiraboon, Passakorn ; Sainamthip, Panot ; Teeyapun, Nattaya...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965854/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Immunogenicity after a Third COVID-19 mRNA Booster in Solid..:

Luangdilok, Sutima ; Wanchaijiraboon, Passakorn ; Pakvisal, Nussara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608216/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in..:

Wanchaijiraboon, Passakorn ; Teeyapun, Nattaya ; Pakvisal, Nussara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609471/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
12

Vaccine-Related adverse events following AZD1222 (ChAdOx1-n..:

Pakvisal, Nussara ; Sainamthip, Panot ; Teeyapun, Nattaya...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746493/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
13

Safety Following COVID-19 Booster Vaccine with BNT162b2 Com..:

Passakorn Wanchaijiraboon ; Panot Sainamthip ; Nattaya Teeyapun...
COVID-19 Vaccines and Vaccination.  , 2023
Link: https://doi.org/10.3390/..
 
?
14

Safety Following COVID-19 Booster Vaccine with BNT162b2 Com..:

Passakorn Wanchaijiraboon ; Panot Sainamthip ; Nattaya Teeyapun...
https://www.mdpi.com/2076-393X/11/2/356.  , 2023
Link: https://doi.org/10.3390/..
 
?
15

Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignan..:

Nattaya Teeyapun ; Sutima Luangdilok ; Nussara Pakvisal...
http://www.sciencedirect.com/science/article/pii/S2589537022003388.  , 2022
Link: https://doi.org/10.1016/..
 
1-15